Clinical Trial Update: SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology [NA]

View source ↗

Summary

SAHARA-04 is a trial evaluating adaptive radiotherapy using ETHOS technology for hypersensitive patients with high locoregional risk breast cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Breast Cancer | NA | Status: RECRUITING